World's Best Scientists 2026 revealed!
Peter G. Kremsner

Peter G. Kremsner

Award Badge
Medicine
Germany
2023

D-Index & Metrics

Medicine

D-Index
114
Citations
49888
World Ranking
4716
National Ranking
256

Research.com Recognitions

  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Peter G. Kremsner is affiliated with the University of Tübingen in Germany and has contributed extensively to the field of medicine, with a particular focus on infectious diseases and public health. Their research encompasses a variety of topics, notably in malaria research and control, mosquito-borne diseases, and COVID-19 related studies.

The scientist has published in several frequent venues, including:

  • International Journal of Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS neglected tropical diseases
  • Harvard Dataverse
  • Scientific Reports

Frequent co-authors of Peter G. Kremsner include:

  • Ayôla Akim Adégnika
  • Benjamin Mordmüller
  • Thirumalaisamy P. Velavan
  • Sélidji Todagbé Agnandji
  • Rolf Fendel

The main fields of study are medicine, especially infectious diseases and public health, with significant contributions to immunology, molecular biology, and parasitology.

Main topics covered in the scientist's work include:

  • Malaria Research and Control
  • Mosquito-borne diseases and control
  • SARS-CoV-2 and COVID-19 Research
  • Parasites and Host Interactions
  • COVID-19 Clinical Research Studies
  • Viral gastroenteritis research and epidemiology
  • COVID-19 epidemiological studies

Selected recent papers authored or co-authored by Peter G. Kremsner are:

  • Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial, 2021, The Lancet Infectious Diseases
  • Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials, 2021, Nature Communications
  • Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible, 2020, International Journal of Infectious Diseases
  • Host genetic factors determining COVID-19 susceptibility and severity, 2021, EBioMedicine
  • Codiversification of gut microbiota with humans, 2022, Science

Best Publications

  • Allergy, Parasites, and the Hygiene Hypothesis

    Maria Yazdanbakhsh;Peter G. Kremsner;Peter G. Kremsner;Ronald van Ree

  • First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

    Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;Solange Solmeheim Soulanoudjingar;Solange Solmeheim Soulanoudjingar

  • Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

    Emmanuel B. Bache;Selidji Todagbe Agnandji;Bertrand Lell;José Francisco Fernandes

  • Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10.

    Anita H. J. Van Den Biggelaar;Ronald Van Ree;Laura C. Rodrigues;Bertrand Lell

  • A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

    Selidji Todagbe Agnandji;Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;José Francisco Fernandes;José Francisco Fernandes

  • A Worldwide Map of Plasmodium Falciparum K13-Propeller Polymorphisms

    Didier Ménard;Nimol Khim;Johann Beghain;Ayola A. Adegnika;Ayola A. Adegnika

  • Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna

  • Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

    Daniel E Neafsey;Michal Juraska;Trevor Bedford;David Benkeser

  • Long-Term Treatment of Intestinal Helminths Increases Mite Skin-Test Reactivity in Gabonese Schoolchildren

    Anita H. J. van den Biggelaar;Anita H. J. van den Biggelaar;Laura C. Rodrigues;Ronald van Ree;Jaring S. van der Zee

  • Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

    Benjamin Mordmüller;Güzin Surat;Heimo Lagler;Heimo Lagler;Sumana Chakravarty

  • A research agenda for malaria eradication: drugs.

    PL Alonso;Q Bassat

  • Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial.

    M. Adjuik;P. Agnamey;A. Babiker;S. Borrmann;S. Borrmann

  • Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

    Michael T. White;Robert Verity;Jamie T. Griffin;Kwaku Poku Asante

  • Interferon-γ Responses Are Associated with Resistance to Reinfection with Plasmodium falciparum in Young African Children

    Adrian J. F. Luty;Bertrand Lell;Ruprecht Schmidt-Ott;Leopold G. Lehman

  • A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses.

    David J. Conway;David R. Cavanagh;Kazuyuki Tanabe;Cally Roper

  • Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials

    John J Aponte;David Schellenberg;Andrea Egan;Alasdair Breckenridge

  • Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria

    A. J. F. Luty;D. J. Perkins;B. Lell;B. Lell;B. Lell;R. Schmidt-Ott;R. Schmidt-Ott

  • Comparison of methods for the rapid laboratory assessment of children with malaria.

    T Planche;S Krishna;M Kombila;K Engel

  • High recombination rate in natural populations of Plasmodium falciparum

    David J. Conway;Cally Roper;Ayoade M. J. Oduola;David E. Arnot

  • Fosmidomycin, a Novel Chemotherapeutic Agent for Malaria

    Bertrand Lell;Bertrand Lell;Ronnatrai Ruangweerayut;Jochen Wiesner;Michel Anoumou Missinou;Michel Anoumou Missinou

Frequent Co-Authors

Bertrand Lell
Bertrand Lell University of Tübingen
Ayola A. Adegnika
Ayola A. Adegnika University of Tübingen
Benjamin Mordmüller
Benjamin Mordmüller Radboud University Medical Center
Saadou Issifou
Saadou Issifou University of Tübingen
Martin P. Grobusch
Martin P. Grobusch University of Amsterdam
Adrian J. F. Luty
Adrian J. F. Luty Institut de Recherche pour le Développement
Maria Yazdanbakhsh
Maria Yazdanbakhsh Leiden University Medical Center
Steffen Borrmann
Steffen Borrmann University of Tübingen
Wolfgang Graninger
Wolfgang Graninger Medical University of Vienna
Frieder Schaumburg
Frieder Schaumburg University of Münster

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medicine in the USA, there are many flexible career paths and online degrees that can help you enter the healthcare field or advance your career. For those interested in nursing, the easiest bsn program to get into may offer fast-track entry options with a less competitive admissions process. Similarly, prospective practical nurses can consider an lpn program no entrance exam to avoid added stress and testing barriers during application.

Not every healthcare career requires a clinical background. Individuals who prefer administrative or behind-the-scenes roles can look into health care administration degree online options to efficiently move into management positions. Another growing pathway is medical coding and billing. There are medical billing and coding schools that accept fafsa, making them accessible for those needing financial aid.

Whether your interest is direct patient care or healthcare operations, a wide range of online degrees and flexible programs can open doors to rewarding careers within the medical field.

Best Scientists Citing Peter G. Kremsner

Trending Scientists